The Titan Biotech Limited has filed with exchange unaudited financial results for the quarter and nine months ended December 31, 2024.
Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Result
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Titan Biotech Limited on 6ix
Story so far
Earlier from Titan Biotech
- Unaudited Financial Result For The Quarter And Nine Months Ended On 31St December, 2024
- Titan Biotech Limited Press Release Feb 03 2025
- Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Financial Results For Quarter Ending On 31St December, 2024
- Titan Biotech Limited Press Release Jan 10 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Titan Biotech
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Integrated Filing (Financial)
- Titan Biotech Limited Press Release Feb 13 2025
- Announcement under Regulation 30 (LODR)-Updates on Acquisition
- Titan Biotech Limited Press Release Feb 28 2025
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech